Aguilar Laura K.
SEC CIK 1873915 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CADL | Candel Therapeutics, Inc. | Chief Medical Off | 223.5K | — | — | 14 | 2021-07-29 | 2024-12-26 |
Most active insiders at CADL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Tak Paul Peter | CEO, Dir | — | $3.16M |
| 2 | Manning Paul B | Dir | $3.00M | — |
| 3 | Barone Francesca | CSO | — | $235.8K |
| 4 | Tyagarajan Seshu | CTO | — | $154.2K |
Aguilar Laura K. made no open-market trades at CADL in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-12-30 | 2024-12-26+ | CADL | Candel Therapeutics, Inc. | Aguilar Laura K. | 10% | D - Sale to Iss | $8.93 | -100.0K | 223.5K | -31% | -$893.0K |
| MI | 2024-12-30 | 2024-12-26+ | CADL | Candel Therapeutics, Inc. | Aguilar Laura K. | 10% | D - Sale to Iss | $8.93 | -100.0K | 131.4K | -43% | -$893.0K |
| MI | 2024-12-26 | 2024-12-20+ | CADL | Candel Therapeutics, Inc. | Aguilar Laura K. | 10% | D - Sale to Iss | $8.84 | -200.0K | 231.4K | -46% | -$1.77M |
| M | 2024-12-26 | 2024-12-20+ | CADL | Candel Therapeutics, Inc. | Aguilar Laura K. | 10% | D - Sale to Iss | $8.84 | -100.0K | 373.5K | -21% | -$883.5K |
| M | 2024-12-06 | 2024-12-04+ | CADL | Candel Therapeutics, Inc. | Aguilar Laura K. | 10% | D - Sale to Iss | $4.83 | -60.0K | 111.3K | -35% | -$289.6K |
| 2024-11-27 | 2024-11-25 | CADL | Candel Therapeutics, Inc. | Aguilar Laura K. | 10% | D - Sale to Iss | $4.97 | -20.0K | 151.3K | -12% | -$99.4K | |
| M | 2024-11-08 | 2024-11-06+ | CADL | Candel Therapeutics, Inc. | Aguilar Laura K. | 10% | D - Sale to Iss | $5.15 | -22.5K | 881.0K | -2% | -$115.8K |
| MI | 2024-11-08 | 2024-11-06+ | CADL | Candel Therapeutics, Inc. | Aguilar Laura K. | 10% | D - Sale to Iss | $5.15 | -22.5K | 846.4K | -3% | -$115.8K |
| M | 2024-11-01 | 2024-10-30+ | CADL | Candel Therapeutics, Inc. | Aguilar Laura K. | 10% | D - Sale to Iss | $5.31 | -21.0K | 903.5K | -2% | -$111.6K |
| MI | 2024-11-01 | 2024-10-30+ | CADL | Candel Therapeutics, Inc. | Aguilar Laura K. | 10% | D - Sale to Iss | $5.31 | -21.0K | 853.9K | -2% | -$111.6K |
| M | 2024-10-28 | 2024-10-24+ | CADL | Candel Therapeutics, Inc. | Aguilar Laura K. | 10% | D - Sale to Iss | $5.57 | -30.9K | 900.2K | -3% | -$172.3K |
| D | 2022-05-10 | 2022-05-06 | CADL | Candel Therapeutics, Inc. | Aguilar Laura K. | 10% | F - Tax | $3.65 | -68.5K | 1.03M | -6% | -$250.1K |
| D | 2022-05-10 | 2022-05-06 | CADL | Candel Therapeutics, Inc. | Aguilar Laura K. | 10% | M - OptEx | $1.46 | +171.3K | 1.10M | +18% | +$250.1K |
| D | 2021-08-02 | 2021-07-29 | CADL | Candel Therapeutics, Inc. | Aguilar Laura K. | Chief Medical Off | C - Cnv Deriv | — | +56.1K | 931.0K | +6% | — |
Purchase Sale Sale after option exercise All abbreviations